Angiopoietin-like protein (Angptl) 1 and Angptl2, which are considered orphan ligands, are highly homologous, particularly in the fibrinogen-like domain containing the putative receptor binding site. This similarity suggests potentially cooperative functions between the two proteins. In this report, the function of Angptl1 and Angptl2 is analyzed by using morpholino antisense technology in zebrafish. Knockdown of both Angptl1 and Angptl2 produced severe vascular defects due to increased apoptosis of endothelial cells at the sprouting stage. In vitro studies showed that Angptl1 and Angptl2 have antiapoptotic activities through the phosphatidylinositol 3-kinase͞Akt pathway, and coinjection of constitutively active Akt͞protein kinase B mRNA rescued impaired vascular development seen in double knockdown embryos. These results provide a physiological demonstration of the cooperative interaction of Angptl1 and Angptl2 in endothelial cells through phosphatidylinositol 3-kinase͞Akt mediated antiapoptotic activities.
D
evelopment of the vascular system occurs as two distinct processes, vasculogenesis and angiogenesis. In vasculogenesis, hemangioblasts derived from the lateral plate mesoderm form tubular structures of the primary vasculature. In angiogenesis, new vessels sprout from preexisting vasculature and are further remodeled to form mature blood vessels. Angiogenesis consists of several activities of endothelial cells, such as migration and apoptosis. Angiopoietin signaling through the Tie2 receptor is widely known to play a key role in angiogenesis (1) (2) (3) (4) (5) (6) (7) .
Angiopoietin (Ang) 1 and all members of the angiopoietin family possess two characteristic structures: a coiled-coil domain, which likely contributes to oligomerization, and a fibrinogen-like domain, thought to contain the receptor binding site. Recently, we (8) (9) (10) and others (11) (12) (13) (14) (15) identified several genes encoding proteins containing both the coiled-coil domain and the fibrinogen-like domain. Although these factors were initially predicted to function as ligands for Tie receptors, they bound neither Tie1 nor Tie2. Therefore, they are currently orphan ligands and designated angiopoietin-like proteins (Angptls) or angiopoietin-related proteins (ARPs). Several studies show that Angptl͞ARP family proteins possess potent activities in the vascular system (8) (9) (10) (11) (12) (13) (14) (15) (16) . Angptl1 and Angptl2 have been reported to possess weak endothelial cell-sprouting activities (11, 12) ; however, there is little information as to their physiological functions.
Zebrafish offer several advantages as a model system for analyzing vascular development. One reason is that rapid external development of a transparent embryo permits visual analysis of phenotypic defects. Not only vascular structures but also apoptotic cells can be clearly visualized in whole-mount specimens (17, 18) . Indeed, zebrafish has been used to investigate several vascular processes, particularly commitment of hemangioblasts (19, 20) and arterial-venous identification (21) (22) (23) (24) . Recently, we cloned the zebrafish orthologues of Angptl1 and Angptl2 (Zangptl1 and Zangptl2, respectively) (25) . Based on the results of a syntenic search by using the genome database and comparing expression patterns between zebrafish and mammals in adult tissues, we determined our isolated Zangptl1 and Zangptl2 are the orthologues of their mammalian counterparts, respectively. In that report, we also described their embryonic expression patterns. Both Zangptl1 and Zangptl2 are expressed mainly in the caudal part of the corpus at Ϸ24 h after fertilization (hpf) when angiogenesis manifested by sprouting of intersomitic vessels (ISVs) occurs. Zangptl1 is expressed in the myotome, and Zangptl2 is predominantly expressed in the yolk sac extension, especially in the yolk syncytial layer and the spinal cord, suggesting that both factors might act on endothelial cells of ISVs sprouting toward such structures. To examine the physiological functions of both genes simultaneously, we used a loss-offunction strategy by using morpholinos, an antisense technology widely used to knockdown multiple genes predicted to act cooperatively (26, 27) . Our studies indicate that both Angptl1 and Angptl2 possess antiapoptotic activity through the phosphatidylinositol 3-kinase (PI3-K)͞Akt pathway and that their cooperative activities are required for vascular development in zebrafish embryogenesis.
Materials and Methods
Zebrafish Maintenance. Zebrafish were kept at standard conditions (28) . Embryos Ͼ24 hpf were raised in 0.2 mM 1-phenyl-2-thio-urea (Sigma) to prevent pigment formation.
Angptl2mo (Angptl2d5), 5Ј-CTAGTcAAcGAAgATCCATcACgAC-3Ј (mismatched bases are indicated by small letters); and the second Zangptl2 morpholino, (Angptl2mo2) designed in 5Ј-UTR of Zangptl2, 5Ј-CACCAGATGATCCCAGGCTATT-GCA-3Ј.
Microinjections. Morpholinos and͞or mRNA were diluted to the indicated concentrations with Danieau buffer (58 mM NaCl͞0.7 mM KCl͞0.4 mM MgSO 4 ͞0.6 mM Ca(NO 3 ) 2 ͞5.0 mM Hepes, pH 7.6) and Ϸ2 nl were injected into the yolk of one-to four-cell stage embryos. The standard control morpholino available from Gene Tools was used as an injection control.
Microangiography. Microangiography was performed as described in ref. 29 . Briefly, FITC-Dextran in Danieau buffer at 2 mg͞ml was injected into the sinus venosa͞cardinal vein of anesthetized embryos. Photographs were taken during observation under a Leica MZFL III dissection microscope equipped with the standard FITC filter set.
Whole-Mount in Situ Hybridization (ISH).
Probes for flk-1, fli-1, myoD, and nkx2.5 genes were cloned by PCR amplification. PCR products were subcloned into the pGEM T-easy vector. Digoxigenin (DIG)-labeled antisense RNA probes were synthesized by using a DIG RNA labeling kit (Roche Diagnostics, Mannheim, Germany). Whole-mount ISH was performed as described in ref. 30 .
Whole-Mount TUNEL Staining. Embryos were fixed in 4% paraformaldehyde at 4°C overnight before staining by using the ApopTag Peroxidase In Situ Apoptosis Detection kit (Chemicon, Temecula, CA) according to the manufacturer's instructions, essentially as described in refs. 17 and 31.
Synthesis of Recombinant COMP-Angptl1 and -Angptl2 Proteins. To investigate the role of Angptl1 and Angptl2 directly, we generated their recombinant proteins. Notably, we designed the Angptl1 variant, COMP-Angptl1, in which the fibrinogen-like domain of mouse Angptl1 was fused to the coiled-coil domain of rat cartilage oligomeric matrix protein (DLAPQMLRELQET-NA A LQDVR ELLRQQVKEITFLKNTVMECDACG) to avoid aggregation and insolubility of Angptl1. COMP-Angptl1 and the native form of mouse Angptl2 fused at the amino terminus to the FLAG epitope were subcloned into pCEP4 (Invitrogen, Groningen, The Netherlands), and recombinant FLAG-tagged proteins (COMP-Angptl1-FLAG and Angptl2-FLAG) were purified as described in refs. 8 and 10. The proteins obtained were visualized by Western blotting with horseradish peroxidase-conjugated anti-FLAG antibody (M2) (Sigma) (see Supporting Materials and Methods, which is published as supporting information on the PNAS web site). As controls in the inhibitor experiments, equivalent amounts of DMSO vehicle were added to the medium. Apoptotic adherent cells were stained by using an ApopTag Fluorescein In Situ Apoptosis Detection Kit (Chemicon). Nuclear staining was done by TOTO3. Cells were observed under a fluorescent microscope.
Synthesis of Myristoylated Akt͞Protein Kinase B (PKB) mRNA.
To prepare the active form of Akt-1͞PKB␣ mRNA, myristoylated human AKT-1͞PKB␣ cDNA (kindly provided by Dr. Kenneth Walsh, Boston University, Boston), which has been reported to have high homology with a zebrafish orthologue and function in zebrafish in vivo (17) , was linearized at the 3Ј end, and capped RNAs were in vitro transcribed by using the Message Machine Kit (Ambion, Austin, TX) as described in refs. 17 and 33.
Results

Loss of Angptl1 and Angptl2 Promotes Vascular Defects.
To evaluate the physiological effect of Angptl1 and Angptl2, we undertook loss-of-function experiments in zebrafish by using morpholinos. Our first observation was embryonic lethality at 72 hpf caused by pericardial effusion. Although the number of embryos with pericardial effusion showed a dose-dependent increase in the Angptl1mo-(Angptl1MO) and Angptl2mo-(Angptl2MO) injected group compared with the standard morpholino-injected group (St), the group injected with both Angptl1mo and Angptl2mo (double morpholino, DMO) showed remarkable increases in the number of embryos with pericardial effusion ( Fig. 1A ; see also Fig. 5 , which is published as supporting information on the PNAS web site). To determine whether defects in heart development occurred at earlier stages, we examined expression of nkx2.5 and found normal expression in DMO embryos (Fig. 6 , which is published as supporting information on the PNAS web site). At 48 hpf, when the heartbeat can be easily observed, the DMO group showed a normal heartbeat similar to the St group (Movies 1 and 2, which are published as supporting information on the PNAS web site). To determine whether pericardial effusion was attributable to defects in vascular development, we observed blood flow in the same embryos. Interestingly, although we detected blood flow in two major trunk vessels, the dorsal aorta (DA) and postcardinal vein, in both St and DMO groups, we could not detect blood flow in ISVs and the dorsal-longitudinal anastomosus vessel in the DMO group as detected in the St group (Movies 3 and 4, which are published as supporting information on the PNAS web site), suggesting that vascular defects precede heart defects. To visualize blood vessel formation at this stage, we performed angiography (Fig. 1B) and ISH for fli-1 (Fig. 1C) . Although the major trunk vessels were clearly detected, ISVs and dorsal-longitudinal anastomosus vessels was undetectable in the DMO group in both experiments. These findings suggest that impaired vascular development is the primary defect seen when Angptl1 and Angptl2 activity is lost.
Loss of Angptl1 and Angptl2 Promotes Impaired Sprouting of ISVs and
Increased Numbers of Apoptotic Cells Around DA. To determine the initiation of vascular defects in DMO, we examined vascular development at early developmental stages by whole-mount ISH of endothelial markers. Vascular defects were first observed as impaired sprouting of ISVs as detected by ISH of flk-1 at 28 hpf. The DMO group showed complete loss of sprouting of ISVs ( Fig.  2A) . Defects of impaired sprouting vessels were quantitatively analyzed as described in refs. 18 and 27. A high percentage of the DMO group showed impaired sprouting (Fig. 7 , which is published as supporting information on the PNAS web site). To confirm the specificity of these findings, we analyzed defects of sprouting vessels by using second morpholinos or morpholinos with five mismatched bases as negative controls (Fig. 8 and 9 , which are published as supporting information on the PNAS web site). In both experiments, we obtained results similar to those seen with the first set of morpholinos.
The formation of hemangioblasts is a very early step in the development of the vascular system. Hemangioblasts form in the lateral plate mesoderm at 12 hpf, and tubular structures of the primary vasculature formed by the hemangioblasts at 18 hpf can be visualized by ISH of fli-1 and flk-1. Formation of such structures was normal in DMO embryos, suggesting normal vasculogenesis can occur in the absence of Angptl1 and Angptl2 (Fig. 2B) .
To investigate the mechanism underlying impaired sprouting, we examined apoptotic cells in vivo by whole-mount TUNEL assay. Apoptotic cells around the DA were markedly increased in the DMO group compared with the control group (Fig. 2 C and D) . On the other hand, there was no significant difference in the number of physiological apoptotic cells in neural tube (31) between St and DMO groups when we counted TUNEL-positive cells in the neural tube within rostral and caudal ends of yolk sac extension (17.9 Ϯ 5.34 and 19.8 Ϯ 5.3, respectively: n ϭ 7, P ϭ 0.53).
Because somitic cells secrete angiogenic factors such as VEGF, normal development of somites is essential for angiogenesis in zebrafish. Thus, we examined somitogenesis and VEGF expression in the DMO group. Somitogenesis appeared normal and no alteration in VEGF expression was observed in the DMO group (Fig. 2E) . These results show that the loss of Angptl1 and Angptl2 promotes impaired sprouting of ISVs and increased apoptotic cells around the DA.
Angptl1 and Angptl2 Bind to Endothelial Cells.
To clarify the mechanism underlying the in vivo phenotype seen in zebrafish after DMO treatment, we performed in vitro studies by using HUVECs. First, we generated FLAG-tagged mouse COMPAngptl1 and -Angptl2 proteins. Although we successfully synthesized the native form of Angptl2, we failed to purify that of Angptl1 because of its unique tendency to aggregate and become insoluble. Although similar difficulties purifying Ang1 have been reported, by replacing the N-terminal portion of Ang1 with a minimal coiled-coil domain from cartilage oligomeric matrix protein (COMP), Koh et al. (34, 35) have succeeded in generating a soluble, stable, and potent Ang1 variant, COMP-Ang1 protein. Using the same strategy, we succeeded in generating a soluble and stable Angptl1 variant, COMP-Angptl1. First, we observed monomeric forms of COMP-Angptl1 and -Angptl2 in the presence of reducing agents, 2-mercaptoethanol (2ME), and multimeric forms in nonreducing conditions without 2-mercaptoethanol by Western blotting with an anti-FLAG antibody (Fig.   3A) . Moreover, we found that COMP-Angptl1 and Angptl2 bound neither Tie1 nor Tie2 (data not shown).
Next, we found that COMP-Angptl1 and Angptl2 show specific binding to HUVECs by FACS analysis. Dose-response binding curves, saturation of binding at a concentration (Fig. 3 B and C) , and greatly decreased binding to other cell types like BaF͞3 and Fao (Fig. 10 , which is published as supporting information on the PNAS web site) suggested that binding between HUVECs and both proteins was specific, and that the affinity of Angptl2 for HUVECs was greater than that of COMP-Angptl1.
The amino acid sequences of Angptl1 and Angptl2 are very similar between mammalian and zebrafish proteins. Homology is particularly high in the fibrinogen-like domain (Fig. 11 , which is published as supporting information on the PNAS web site). Such homology, combined with the fact that the in vivo phenotype in zebrafish was particularly robust in double knockdown embryos, suggested a cooperative role of Angptl1 and Angptl2, most likely through a putative common receptor. When HUVECs were pretreated with Angptl2-FLAG, binding of biotinylated COMP-Angptl1 on HUVECs was completely inhibited. In parallel, similar, but partial, inhibition of binding between COMP-Angptl1-FLAG and HUVECs was observed when the converse experiments were performed, (Fig. 12 , which is published as supporting information on the PNAS web site). These findings may support a possibility of the cooperative function of Angptl1 and Angptl2 through a common receptor, although further analysis for identifying their cognate receptor will be necessary.
Angptl1 and Angptl2 Possess Antiapoptotic Activity Through the PI3-K͞Akt Pathway. When HUVECs were treated with COMPAngptl1 or Angptl2, phosphorylation of ERK1͞2 and Akt was observed, peaking 10 min after treatment (Fig. 3D) . No effect on BaF͞3 and Fao cells was detected (Fig. 13 , which is published as supporting information on the PNAS web site). Furthermore, no effect on p38 MAPK and JNK in HUVECs was seen (data not shown). We next examined the biological activities of COMPAngptl1 and -Angptl2 on HUVECs. Because the ERK1͞2 pathway is a major intracellular signaling pathway activated by factors that promote endothelial proliferation, we examined proliferative activity by BrdUrd incorporation. Although VEGF used as a control significantly promoted BrdUrd incorporation, neither COMP-Angptl1 nor Angptl2 stimulated significant increases in BrdUrd incorporation (Fig. 14, which is published as supporting information on the PNAS web site). We next examined antiapoptotic activity of COMP-Angptl1 and -Angptl2 on HUVECs. The numbers of apoptotic cells were significantly decreased in both COMP-Angptl1 and -Angptl2-treated groups based on TUNEL assays (Fig. 3E) and Annexin V assays (Fig.  15 , which is published as supporting information on the PNAS web site). Finally, to evaluate whether MEK or PI3-K is involved in the antiapoptotic activity of COMP-Angptl1 and -Angptl2, we reexamined apoptotic activity in the presence of their respective inhibitors, PD98059 or LY294002. As compared with controls treated with equivalent amounts of DMSO, LY294002, but not PD98059, significantly inhibited antiapoptotic activity of CompAngptl1 and Angptl2 as seen in TUNEL and AnnexinV assays (Figs. 3E and 15 ). These findings suggest that antiapoptotic activity on HUVECs induced by COMP-Angptl1 and -Angptl2 is mediated by the PI3-K͞Akt pathway.
Coinjection of Constitutive Active Akt Rescues Vascular Defects In-
duced by Loss of Angptl1 and Angptl2. Based on our in vitro studies, we examined whether activation of Akt by coinjection of myristoylated Akt-1͞PKB␣ mRNA (myr-Akt) rescued the vascular defects seen in DMO embryos. First, by titration experiments, we found a 50-pg injection was the appropriate dose for rescue experiments. Higher doses of Akt mRNA produced severe defects leading to early lethality (data not shown). At the optimal dose, up-regulated Akt͞PKB activity rescued impaired angiogenesis seen in the DMO group. As a control, coinjection of the equivalent amount of EGFP mRNA did not rescue defects (Fig.  4 A and B) . Although coinjected EGFP activity was almost undetectable at 48 hpf, we detected abundant EGFP expression in the trunks of embryos at 24 hpf (Fig. 4C) , suggesting that myr-Akt mRNA is likely active at 24 hpf when sprouting of ISVs occurs.
Discussion
In previous reports, Angptl1 and Angptl2 were shown to possess pro-or antiangiogenic activity. However, there are few reports regarding the physiological role of either protein in vivo. In this report, a morpholino antisense strategy in zebrafish showed that Angptl1 and Angptl2 function cooperatively in embryonic angiogenesis through antiapoptotic activity. In addition, both Angptl1 and Angptl2 activate PI3-K͞Akt and inhibit apoptosis in cultured endothelial cells. Furthermore, we showed that activation of Akt could rescue the vascular defects induced by loss of Angptl1 and Angptl2.
Recently, we showed that in zebrafish Zangptl1 is expressed in the myotome, and Zangptl2 is expressed mainly in the spinal cord and yolk syncytial layer at the time angiogenesis occurs (25) . In this report, we demonstrate that loss of function of both proteins leads to vascular defects, specifically in the sprouting of ISVs. ISVs sprout and extend toward the dorsal side of embryos between the myotome and spinal cord. Therefore, one hypothesis is that Angptl1 and Angptl2 secreted from nearby structures acts together on endothelial cells of ISVs as survival factors through activation of the PI3-K͞Akt pathway.
In initial reports, Kim et al. (11, 12) reported that both Angptl1 and Angptl2 have significant but weak endothelial cell-sprouting activities in vitro. Later, it was reported that Angptl1 inhibited VEGF-induced angiogenesis, and it was thus named ''Angioarrestin'' (16) . These authors also proposed that not only Angptl1 but Angptl2 might be antiangiogenic factors. In our hands, Angptl1 stimulated phosphorylation of ERK1͞2 and Akt and had significant antiapoptotic activity on HUVECs. Angptl1 may function as either a pro-or antiangiogenic factor, depending on cell context, and it is possible that the primary function of Angptl1 on endothelial cells is an antiapoptotic activity, not an effect on proliferation and sprouting. Our in vivo results obtained in zebrafish support that hypothesis: minor vascular defects were seen in Angptl2 knockdown embryos, whereas Angptl1 knockdown embryos showed few vascular abnormalities. Based on the severe defects seen in double knockdown embryos, we suggest that Angptl1 may play a regulatory role for the dominant function of Angptl2 in the process of angiogenesis; Angptl1 may exhibit proangiogenic activity particularly in the absence of Angptl2.
Angiopoietins have been shown to play critical antiapoptotic roles in mammals, similar to findings reported here concerning zebrafish Angptl1 and Angptl2. Our findings prompted us to initiate comparative studies between Angiopoietins and Angptl families. The genes encoding zebrafish Ang1 (Zang1) and Ang2 (Zang2) are expressed in the mesenchyme surrounding major trunk vessels (36) . Notably, zebrafish Tie-2 is abundantly expressed in postcardinal vein, but not in the DA (37), whereas differences of expression patterns of Tie2 between the DA and postcardinal vein are not seen in mammals. Our data in zebrafish shows that the effect of loss of Angptl1 and Angptl2 was predominantly in arterial angiogenesis. It is important to determine whether Angiopoietin and Angptl signaling are transduced differentially in arterial and venous angiogenesis in zebrafish.
In conclusion, we have shown that the cooperative interactions of Angptl1 and Angptl2 are required for vascular development of zebrafish in vivo. We have also shown that Angptl1 and Angptl2 bind to the endothelial cells and both have antiapoptotic activities through the PI3-K͞Akt pathway in vitro. Identification of a receptor of Angptl1 and Angptl2 is essential for the further analysis of the functional relationships between Angiopoietins and Angptls. 
